Company · London
Cancer Research Horizons Limited
Research and experimental development on biotechnology
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Cancer Research Horizons Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 30
- Andrew Jonathan Waldron 2003-2021 View profile
- Harpal Singh Kumar 2002-2007 View profile
- Dr Keith Stuart Blundy 2002-2017 View profile
- Sir David Kennedy Newbigging 2002-2002 View profile
- Roy William John Foster 2000-2002 View profile
- Peter David King 2000-2001 View profile
- LEE, Melanie Georgina, Doctor 2000-2002 View profile
- Professor Peter Joseph Parker 1999-2002 View profile
- Sir James David Francis Barnes 1999-2002 View profile
- Dr Clive Adrian Stanway 1999-2013 View profile
- Dr John Tooze 1996-2002 View profile
- Sir Paul Maxime Nurse 1996-2002 View profile
- Professor John O'Grady 1995-2002 View profile
- John Kenneth Wall 1995-2002 View profile
- Sir Derek Harry Roberts 1994-1999 View profile
- Sir Brian Mansel Richards 1994-1999 View profile
- William Cullingford House 1996 View profile
- Dr Michael Joseph Crumpton 1999 View profile
- Ronald Edward Artus 1998 View profile
- Hon Seymour Henry Fortescue 1995 View profile
- Sir Walter Bodmer 1998 View profile
- Sir John Robert Vane 1999 View profile
- Dr Charles Jonathan Gee 1993 View profile
- Professor Peter Walker 1993 View profile
- Professor Sir Nicholas Alcwyn Wright 1994 View profile
- Sir Nigel Frederick Althaus 2000 View profile
- Diane Elizabeth Scott 2001-2003 View profile
- Martin Christopher Ryan 1997-1999 View profile
- Colin Leslie Pointer 1993 View profile
- Madeleine Jennifer Craggs 1997 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
About
- What it does
- Research and experimental development on biotechnology
- Incorporated
- 06/09/1982
- Registered office
- London
- Previous names
- Imperial Cancer Research Technology Limited (until 08/04/2022)
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Cancer Research Technology Limited
75-100% shares, 75-100% voting, appoints directors · notified 2022-08-01
Group
- Cancer Research Horizons Limited
is controlled by Cancer Research Technology Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2022-08-01 · source: Companies House PSC register - Cancer Research Technology Limited
is controlled by Cancer Research UK
Evidence
active 75-100% shares, appoints directors · notified 2022-08-01 · source: Companies House PSC register
Ultimately controlled by Cancer Research UK.
12 other companies in this group
- Cancer Research Scotland Institute Limited
- Beatson Institute for Cancer Research
- Beatson Technology Limited
- Oligotune LTD
- Cancer Research Ventures Limited
- The Cancer Research Campaign
- Cancer Research UK Pension Trustee Limited
- The North of England Cancer Research Campaign
- Cancer Research Technology Limited
- Cancer Research UK Trading Limited
- Cancer Research UK Scotland Institute Limited
- Cancer Research UK
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 01662284
- Status
- Active
- Type
- Private Limited Company
- Accounts next due
- 31/12/2027
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data